USX:UROV - Urovant Sciences Ltd Urovant Sciences Ltd
Sector: Health Care, Industry: Pharmaceuticals
Add to Watchlist
   
Add Alert 


Yahoo Finance
Note: This stock seems to be inactive

USD 16.24    +0.0 (+0%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

29 Mar 2021


Loading...
Loading...
Loading...

General

CEO: Mr. James A. Robinson Jr.

IPO: 2018-09-27

Headquarters: US

Employees: 70

Homepage

Description

Urovant Sciences Ltd is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing therapies for urologic conditions. The company's pipeline products include Overactive Bladder (OAB), OAB in Men with Benign Prostatic Hyperplasia (BPH), and IBS-Associated Pain.